ACAD — ACADIA Pharmaceuticals Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

Trend Edge Setup Score

Trend Edge rates ACAD Bullish with a Setup Score of 8, net conviction 32, actionability 2. How the Setup Score works →

Total Setup Score8
Directional BiasBullish
Net Conviction32
Actionability2 (in range)

Key signals behind this score

About ACADIA Pharmaceuticals Inc

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America. The company offers NUPLAZID (pimavanserin), a selective serotonin inverse agonist/antagonist for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis; and DAYBUE, a novel synthetic analog of the amino-terminal tripeptide of insulin-like gr… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$26.22
Market Cap$4.52B
Float127.2M
Shares Outstanding171.2M
P/E (Forward)77.52
P/E (TTM)11.79
Price/Sales (TTM)4.13
vs. Analyst Target+24.5% to analyst PT
Profit Margin34.30%
Operating Margin (TTM)-1.72%
Revenue (TTM)$1.10B
Earnings Growth (YoY)-81.80%
Dividend RateNone
Analyst Target Price$32.65 (20 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $442M -$282M $421M -$284M
2021 $484M -$168M $465M -$167M
2022 $517M -$216M $507M -$222M
2023 $726M -$61.3M $681M -$45.5M
2024 $958M $226M $876M $100M
2025 $1.07B $391M $983M $151M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $265M $26.7M
Sep 2025 $279M $71.8M
Dec 2025 $284M $274M
Mar 2026 $268M $3.6M

Ownership & Float

Insider Ownership0.3%
Institutional Ownership98.9%
Short Float9.3%
% of All Funds Holding3.84%
Number of Funds Holding316

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$22.83Near-term / short-term trend
Weekly40-Week SMA$23.45Medium-term trend
Weekly80-Week SMA$21.89Cyclical trend (business cycle)
Weekly200-Week SMA$20.82Secular trend (multi-year)
Monthly10-Month SMA$24.20Near-term monthly trend
Monthly20-Month SMA$22.21Medium-term monthly trend
Monthly40-Month SMA$21.59Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$14.70 support 1.50x 13 months ago

Historical Earnings Reactions (88 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -0.22% 0.00% 48.86% 17.27% -18.30%
1 Day -0.35% -1.30% 43.18% 20.99% -20.03%
1 Week -0.85% 0.55% 51.14% 34.46% -25.00%
2 Weeks 0.49% -1.52% 44.32% 96.28% -54.40%
1 Month 5.43% -0.98% 47.13% 130.90% -58.44%

Next earnings: August 5, 2026 (23 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan5.8%50.0%22
Feb2.4%63.6%22
Mar5.0%40.9%22
Apr0.1%45.5%22
May5.7%54.5%22
Jun-0.7%52.2%23
Jul5.3%59.1%22
Aug1.4%54.5%22
Sep2.4%50.0%22
Oct-2.5%45.5%22
Nov3.2%45.5%22
Dec6.0%54.5%22

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.46% 49.1% 1041
Tuesday -0.01% 45.5% 1142
Wednesday 0.03% 48.5% 1142
Thursday 0.20% 47.2% 1120
Friday 0.11% 47.2% 1114

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 98.9%

Insider Transactions — Smart Summary

Total insider ownership: 0.3%

12-Month Insider Activity Summary

Total Filings18
Net Value-$2.3M
Net Shares Change-12,002
% of Float-0.0%
C-Suite Filings16
Clusters Detected2

Key Insiders

NameTitleNet ValueFilingsActivity
Daly James M -$670,983 1 1 sell
Kihara James PRINCIPAL ACCOUNTING OFFICER -$412,305.397 2 1 sell
Owen Adams Catherine Chief Executive Officer -$249,932.27 1 N/A
Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC -$245,021.68 2 N/A
Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER -$235,531.413 2 N/A
Thompson Elizabeth H.Z. EVP, Head of Research & Dev -$73,749.45 1 N/A
GAROFALO ELIZABETH A. -$41,560.48 1 1 sell

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2025-11-12 – 2025-11-19 3 3 -$1.0M 2 C-suite
2026-03-26 – 2026-04-07 7 5 -$690,249.221 7 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-05-27 Kihara James PRINCIPAL ACCOUNTING OFFICER -$114,393.18 Transaction at $21.18, now +23.8%
2026-06-29 Kihara James PRINCIPAL ACCOUNTING OFFICER -$297,912.217 Transaction at $26.08, now +0.5%
2025-11-12 Daly James M -$670,983 Transaction at $22.37, now +17.2%
2025-09-03 GAROFALO ELIZABETH A. -$41,560.48 Transaction at $25.98, now +0.9%
2026-05-05 Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER -$76,395.74 Transaction at $21.79, now +20.3%
2026-03-26 Thompson Elizabeth H.Z. EVP, Head of Research & Dev -$73,749.45 Transaction at $21.47, now +22.1%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for ACADIA Pharmaceuticals Inc (ACAD) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for ACAD on Trend Edge →